+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Benign Prostatic Hyperplasia Treatment Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • PDF Icon

    Report

  • 96 Pages
  • April 2024
  • Region: Global
  • Prof Research
  • ID: 5968910
Description Jump to:

Quick Summary:

In the dynamic landscape of Benign Prostatic Hyperplasia (BPH) treatment drugs, staying ahead with comprehensive market insights is paramount for senior executives plotting strategic initiatives. Our in-depth report is a pivotal resource for understanding the ever-evolving BPH treatment drug market, catering to those resilient in fortifying their competitive edge.

Structured to enhance decision-making, this report delves into regional nuances, from supply and demand fluctuations to granular analyses of market prices. With meticulous profiling of both leading and emerging players, the report is crafted to furnish a 360-degree view of the industry. It is armed with SWOT analyses, business perspectives, and critical parameters, such as revenue trajectories and market share statistics. By procuring this report, you are equipping your enterprise with the knowledge to thrive in a complex, commercially crucial field.

This report describes the global market size of Benign Prostatic Hyperplasia Treatment Drug from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Benign Prostatic Hyperplasia Treatment Drug as well as some smaller players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Types Segment:

  • Alpha blockers (Alfuzosin; Doxazosin; Tamsulosin; Terazosin; Silodosin)
  • 5-alpha reductase inhibitors (Dutasteride; Finasteride)
  • PDE5 inhibitors (Tadalafil)
  • Anticholinergics (Oxybutynin; Tolterodine)
  • beta-3 agonists (Solifenacin; Mirabegron)

Companies Covered:

  • Sanofi
  • Pfizer
  • AbbVie
  • Viatris
  • Waylis Therapeutics
  • Organon
  • Eli Lilly
  • Johnson & Johnson
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Benign Prostatic Hyperplasia Treatment Drug Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Benign Prostatic Hyperplasia Treatment Drug Market in North America (2019-2029)
8.1 Benign Prostatic Hyperplasia Treatment Drug Market Size
8.2 Benign Prostatic Hyperplasia Treatment Drug Market by End Use
8.3 Competition by Players/Suppliers
8.4 Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Benign Prostatic Hyperplasia Treatment Drug Market in South America (2019-2029)
9.1 Benign Prostatic Hyperplasia Treatment Drug Market Size
9.2 Benign Prostatic Hyperplasia Treatment Drug Market by End Use
9.3 Competition by Players/Suppliers
9.4 Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Benign Prostatic Hyperplasia Treatment Drug Market in Asia & Pacific (2019-2029)
10.1 Benign Prostatic Hyperplasia Treatment Drug Market Size
10.2 Benign Prostatic Hyperplasia Treatment Drug Market by End Use
10.3 Competition by Players/Suppliers
10.4 Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Benign Prostatic Hyperplasia Treatment Drug Market in Europe (2019-2029)
11.1 Benign Prostatic Hyperplasia Treatment Drug Market Size
11.2 Benign Prostatic Hyperplasia Treatment Drug Market by End Use
11.3 Competition by Players/Suppliers
11.4 Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Benign Prostatic Hyperplasia Treatment Drug Market in MEA (2019-2029)
12.1 Benign Prostatic Hyperplasia Treatment Drug Market Size
12.2 Benign Prostatic Hyperplasia Treatment Drug Market by End Use
12.3 Competition by Players/Suppliers
12.4 Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Benign Prostatic Hyperplasia Treatment Drug Market (2019-2024)
13.1 Benign Prostatic Hyperplasia Treatment Drug Market Size
13.2 Benign Prostatic Hyperplasia Treatment Drug Market by End Use
13.3 Competition by Players/Suppliers
13.4 Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
Chapter 14 Global Benign Prostatic Hyperplasia Treatment Drug Market Forecast (2024-2029)
14.1 Benign Prostatic Hyperplasia Treatment Drug Market Size Forecast
14.2 Benign Prostatic Hyperplasia Treatment Drug Application Forecast
14.3 Competition by Players/Suppliers
14.4 Benign Prostatic Hyperplasia Treatment Drug Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Sanofi
15.1.1 Company Profile
15.1.2 Main Business and Benign Prostatic Hyperplasia Treatment Drug Information
15.1.3 SWOT Analysis of Sanofi
215.1.4 Sanofi Benign Prostatic Hyperplasia Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
15.2 Pfizer
15.2.1 Company Profile
15.2.2 Main Business and Benign Prostatic Hyperplasia Treatment Drug Information
15.2.3 SWOT Analysis of Pfizer
215.2.4 Pfizer Benign Prostatic Hyperplasia Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
15.3 AbbVie
15.3.1 Company Profile
15.3.2 Main Business and Benign Prostatic Hyperplasia Treatment Drug Information
15.3.3 SWOT Analysis of AbbVie
215.3.4 AbbVie Benign Prostatic Hyperplasia Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
15.4 Viatris
15.4.1 Company Profile
15.4.2 Main Business and Benign Prostatic Hyperplasia Treatment Drug Information
15.4.3 SWOT Analysis of Viatris
215.4.4 Viatris Benign Prostatic Hyperplasia Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
15.5 Waylis Therapeutics
15.5.1 Company Profile
15.5.2 Main Business and Benign Prostatic Hyperplasia Treatment Drug Information
15.5.3 SWOT Analysis of Waylis Therapeutics
215.5.4 Waylis Therapeutics Benign Prostatic Hyperplasia Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
15.6 Organon
15.6.1 Company Profile
15.6.2 Main Business and Benign Prostatic Hyperplasia Treatment Drug Information
15.6.3 SWOT Analysis of Organon
215.6.4 Organon Benign Prostatic Hyperplasia Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
15.7 Eli Lilly
15.7.1 Company Profile
15.7.2 Main Business and Benign Prostatic Hyperplasia Treatment Drug Information
15.7.3 SWOT Analysis of Eli Lilly
215.7.4 Eli Lilly Benign Prostatic Hyperplasia Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
15.8 Johnson & Johnson
15.8.1 Company Profile
15.8.2 Main Business and Benign Prostatic Hyperplasia Treatment Drug Information
15.8.3 SWOT Analysis of Johnson & Johnson
215.8.4 Johnson & Johnson Benign Prostatic Hyperplasia Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Benign Prostatic Hyperplasia Treatment Drug Report
Table Data Sources of Benign Prostatic Hyperplasia Treatment Drug Report
Table Major Assumptions of Benign Prostatic Hyperplasia Treatment Drug Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Benign Prostatic Hyperplasia Treatment Drug Picture
Table Benign Prostatic Hyperplasia Treatment Drug Classification
Table Benign Prostatic Hyperplasia Treatment Drug Applications
Table Drivers of Benign Prostatic Hyperplasia Treatment Drug Market
Table Restraints of Benign Prostatic Hyperplasia Treatment Drug Market
Table Opportunities of Benign Prostatic Hyperplasia Treatment Drug Market
Table Threats of Benign Prostatic Hyperplasia Treatment Drug Market
Table COVID-19 Impact For Benign Prostatic Hyperplasia Treatment Drug Market
Table Raw Materials Suppliers
Table Different Production Methods of Benign Prostatic Hyperplasia Treatment Drug
Table Cost Structure Analysis of Benign Prostatic Hyperplasia Treatment Drug
Table Key End Users
Table Latest News of Benign Prostatic Hyperplasia Treatment Drug Market
Table Merger and Acquisition
Table Planned/Future Project of Benign Prostatic Hyperplasia Treatment Drug Market
Table Policy of Benign Prostatic Hyperplasia Treatment Drug Market
Table 2019-2029 North America Benign Prostatic Hyperplasia Treatment Drug Market Size
Figure 2019-2029 North America Benign Prostatic Hyperplasia Treatment Drug Market Size and CAGR
Table 2019-2029 North America Benign Prostatic Hyperplasia Treatment Drug Market Size by Application
Table 2019-2024 North America Benign Prostatic Hyperplasia Treatment Drug Key Players Revenue
Table 2019-2024 North America Benign Prostatic Hyperplasia Treatment Drug Key Players Market Share
Table 2019-2029 North America Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
Table 2019-2029 United States Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Canada Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Mexico Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 South America Benign Prostatic Hyperplasia Treatment Drug Market Size
Figure 2019-2029 South America Benign Prostatic Hyperplasia Treatment Drug Market Size and CAGR
Table 2019-2029 South America Benign Prostatic Hyperplasia Treatment Drug Market Size by Application
Table 2019-2024 South America Benign Prostatic Hyperplasia Treatment Drug Key Players Revenue
Table 2019-2024 South America Benign Prostatic Hyperplasia Treatment Drug Key Players Market Share
Table 2019-2029 South America Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
Table 2019-2029 Brazil Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Argentina Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Chile Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Peru Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Asia & Pacific Benign Prostatic Hyperplasia Treatment Drug Market Size
Figure 2019-2029 Asia & Pacific Benign Prostatic Hyperplasia Treatment Drug Market Size and CAGR
Table 2019-2029 Asia & Pacific Benign Prostatic Hyperplasia Treatment Drug Market Size by Application
Table 2019-2024 Asia & Pacific Benign Prostatic Hyperplasia Treatment Drug Key Players Revenue
Table 2019-2024 Asia & Pacific Benign Prostatic Hyperplasia Treatment Drug Key Players Market Share
Table 2019-2029 Asia & Pacific Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
Table 2019-2029 China Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 India Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Japan Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 South Korea Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Southeast Asia Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Australia Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Europe Benign Prostatic Hyperplasia Treatment Drug Market Size
Figure 2019-2029 Europe Benign Prostatic Hyperplasia Treatment Drug Market Size and CAGR
Table 2019-2029 Europe Benign Prostatic Hyperplasia Treatment Drug Market Size by Application
Table 2019-2024 Europe Benign Prostatic Hyperplasia Treatment Drug Key Players Revenue
Table 2019-2024 Europe Benign Prostatic Hyperplasia Treatment Drug Key Players Market Share
Table 2019-2029 Europe Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
Table 2019-2029 Germany Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 France Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 United Kingdom Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Italy Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Spain Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Belgium Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Netherlands Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Austria Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Poland Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Russia Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 MEA Benign Prostatic Hyperplasia Treatment Drug Market Size
Figure 2019-2029 MEA Benign Prostatic Hyperplasia Treatment Drug Market Size and CAGR
Table 2019-2029 MEA Benign Prostatic Hyperplasia Treatment Drug Market Size by Application
Table 2019-2024 MEA Benign Prostatic Hyperplasia Treatment Drug Key Players Revenue
Table 2019-2024 MEA Benign Prostatic Hyperplasia Treatment Drug Key Players Market Share
Table 2019-2029 MEA Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
Table 2019-2029 Egypt Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Israel Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 South Africa Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Gulf Cooperation Council Countries Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2029 Turkey Benign Prostatic Hyperplasia Treatment Drug Market Size
Table 2019-2024 Global Benign Prostatic Hyperplasia Treatment Drug Market Size by Region
Table 2019-2024 Global Benign Prostatic Hyperplasia Treatment Drug Market Size Share by Region
Table 2019-2024 Global Benign Prostatic Hyperplasia Treatment Drug Market Size by Application
Table 2019-2024 Global Benign Prostatic Hyperplasia Treatment Drug Market Share by Application
Table 2019-2024 Global Benign Prostatic Hyperplasia Treatment Drug Key Vendors Revenue
Figure 2019-2024 Global Benign Prostatic Hyperplasia Treatment Drug Market Size and Growth Rate
Table 2019-2024 Global Benign Prostatic Hyperplasia Treatment Drug Key Vendors Market Share
Table 2019-2024 Global Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
Table 2019-2024 Global Benign Prostatic Hyperplasia Treatment Drug Market Share by Type
Table 2024-2029 Global Benign Prostatic Hyperplasia Treatment Drug Market Size by Region
Table 2024-2029 Global Benign Prostatic Hyperplasia Treatment Drug Market Size Share by Region
Table 2024-2029 Global Benign Prostatic Hyperplasia Treatment Drug Market Size by Application
Table 2024-2029 Global Benign Prostatic Hyperplasia Treatment Drug Market Share by Application
Table 2024-2029 Global Benign Prostatic Hyperplasia Treatment Drug Key Vendors Revenue
Figure 2024-2029 Global Benign Prostatic Hyperplasia Treatment Drug Market Size and Growth Rate
Table 2024-2029 Global Benign Prostatic Hyperplasia Treatment Drug Key Vendors Market Share
Table 2024-2029 Global Benign Prostatic Hyperplasia Treatment Drug Market Size by Type
Table 2024-2029 Benign Prostatic Hyperplasia Treatment Drug Global Market Share by Type

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Sanofi
  • Pfizer
  • AbbVie
  • Viatris
  • Waylis Therapeutics
  • Organon
  • Eli Lilly
  • Johnson & Johnson
  • Astellas Pharma

Methodology

Loading
LOADING...

Related Topics

Related Reports

Global Benign Prostatic Hyperplasia Treatment Market by Therapeutic Class (5-Alpha Reductase Inhibitor, Alpha-Blocker, Phosphodiesterase-5 Inhibitor), Therapy (Combination Drug Therapy, Mono Drug Therapy), End User - Forecast 2024-2030 - Product Image

Global Benign Prostatic Hyperplasia Treatment Market by Therapeutic Class (5-Alpha Reductase Inhibitor, Alpha-Blocker, Phosphodiesterase-5 Inhibitor), Therapy (Combination Drug Therapy, Mono Drug Therapy), End User - Forecast 2024-2030

  • Report
  • 188 Pages
  • Global
From
Benign Prostatic Hyperplasia Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Benign Prostatic Hyperplasia Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 144 Pages
  • Global
From
Global Benign Prostatic Hyperplasia Treatment Devices Market - Product Image

Global Benign Prostatic Hyperplasia Treatment Devices Market

  • Report
  • 200 Pages
  • Global
From
Benign Prostatic Hyperplasia Treatment Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Benign Prostatic Hyperplasia Treatment Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 183 Pages
  • Global
From
2024 Global Forecast for Benign Prostatic Hyperplasia Treatment Market (2025-2030 Outlook)-High Tech & Emerging Markets Report - Product Image

2024 Global Forecast for Benign Prostatic Hyperplasia Treatment Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.